CCrest is a cGMP specialized Controlled Drugs & Substances enterprise operating under Health Canada Drug Establishment Licenses at its state-of-the-art laboratory facilities located in Montreal.CCrest focuses on its goals to:- Continue progress fighting microbial threats and Anti-Microbial Resistance, especially salmonella, listeria and pseudomonas, focused on its groundbreaking environmental detection tests with Inilbio, and novel antibiotic platform with MHCombiotic;- Continue to advance psychedelic drug research for assisting psychotherapeutic care: a key objective of CCrest this year is to synthesize LSD in its lab, and innovate in formulating MDMA, psilocybin, DMT and mescaline for mental health therapeutic purposes, and avance through regulatory phases;- Expand its drug quality control capabilities and method portfolio by broadening the scope of Research & Development;- Expand drug development and therapeutic discovery efforts to tackle other urgent health threats.